Do dopamine receptors mediate part of MAC?

Anesthesia and Analgesia

Volumn 103, Issue 5, 2006, Pages 1177-1181

  Tanifuji, Yasumasa ^b   Zhang, Yi ^c   Liao, Mark ^a   Eger II, Edmond I ^a,d   Laster, Michael J ^a   Sonner, James M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c FUWAI HOSPITAL   (China)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPROPANE; DESFLURANE; DOPAMINE 2 RECEPTOR; DROPERIDOL; ETOMIDATE; HALOTHANE; ISOFLURANE; SEVOFLURANE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; NOCICEPTIVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING;

ANESTHETICS, INHALATION; ANIMALS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HALOTHANE; ISOFLURANE; MALE; PULMONARY ALVEOLI; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE;

EID: 33750340071     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000244334.52163.a3     Document Type: Article

References (17)

1. Johnston RR, Way WL, Miller RD. Alteration of anesthetic requirement by amphetamine. Anesthesiology 1972;36:357-63.
2. Miller RD, Way WL, Eger EI II. The effects of alpha-methyldopa, reserpine, guanethidine, and iproniazid on minimum alveloar anesthetic requirement (MAC). 1968;29:1153-8.
3. Segal IS, Walton JK, Irwin I, et al. Modulating role of dopamine on anesthetic requirements. Eur J Pharmacol 1990;186:9-15.
4. Onozawa H, Miyano K, Tanifuji Y. Effect of dopamine content in rat brain striatum on anesthetic requirement: an in vivo microdialysis study. Brain Res 1999;817:192-5.
5. Antognini JF, Schwartz K. Exaggerated anesthetic requirements in the preferentially anesthetized brain. Anesthesiology 1993;79:1244-9.
6. Antognini JF, Carstens E, Atherley R. Does the immobilizing effect of thiopental in brain exceed that of halothane? Anesthesiology 2002;96:980-6.
7. Rampil IJ, Mason P, Singh H. Anesthetic potency (MAC) is independent of forebrain structures in the rat. Anesthesiology 1993;78:707-12.
8. Eger EI II, Liao M, Laster MJ, et al. Contrasting roles of the NMDA receptor in the production of immobilization by conventional and aromatic anesthetics. Anesth Analg 2006;102:1397-406.
9. Seeman P, Ko F, Tallerico T. Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics. Mol Psychiatry 2005;10:877-83.
10. Jurd R, Arras M, Lambert S, et al. General anesthetic actions in vivo strongly attenuated by a point mutation in the GABA(A) receptor β-3 subunit. FASEB J 2003;17:250-2.
11. Liao M, Sonner JM, Jurd R, et al. β-3-containing γ-aminobutyric acidA receptors are not major targets for the amnesic and immobilizing actions of isoflurane. Anesth Analg 2005;101:412-18.
12. Adachi YU, Yamada S, Satomoto M, et al. Isoflurane anesthesia induces biphasic effect on dopamine release in the rat striatum. Brain Res Bull 2005;67:176-81.
13. Belelli D, Muntoni AL, Merrywest SD, et al. The in vitro and in vivo enantioselectivity of etomidate implicates the GABAA receptor in general anaesthesia. Neuropharmacology 2003;45:57-71.
14. Flood P, Krasowski MD. Intravenous anesthetics differentially modulate ligand-gated ion channels. Anesthesiology 2000;92:1418-25.
15. Hamik A, Peroutka SJ. Differential interactions of traditional and novel antiemetics with dopamine D2 and 5-hydroxytryptamine3 receptors. Cancer Chemother Pharmacol 1989;24:307-10.
16. Frussa-Filho R, Palermo-Neto J. Effects of single and long-term droperidol administration on open-field and stereotyped behavior of rats. Physiol Behav 1991;50:825-30.
17. Nowak K, Welsch-Kunze S, Kuschinsky K. Conditioned tolerance to haloperidol- and droperidol-induced catalepsy. Naunyn-Schmiedeberg's Arch Pharmacol 1988;337:385-91.